Statistical Considerations for Quantitative Imaging Measures in Clinical Trials
Publisher
Springer Singapore
Reference19 articles.
1. Alonso, A., Molenberghs, G., Geys, H., Buyse, M., & Vangeneugden, T. (2006). A unifying approach for surrogate marker validation based on Prentice’s criteria. Statistics in Medicine, 25(2), 205–221. 2. Engelke, K., & Glüer, C. C. (2006). Quality and performance measures in bone densitometry. Part 1: Errors and diagnosis. Osteoporosis International, 17(9), 1283–1292. 3. Hillman, B. J. (2005). ACRIN—Lessions learned in conducting multi-center trials of imaging and cancer. Cancer Imaging, 5, Spec No A:S97-101. PMID: 16361142. 4. Kalender, W. A., Felsenberg, D., Genant, H. K., Fischer, M., Dequeker, J., & Reeve, J. (1995). The European Spine Phantom—A tool for standardization and quality control in spinal bone mineral measurements by DXA and QCT. European Journal of Radiology, 20(2), 83–92. 5. Keshavan, A., Paul, F., Beyer, M. K., et al. (2016). Power estimestimationatino for non-standardized multisite studies. Neuroimage, 134, 281–294.
https://doi.org/10.1016/j.neuroimage.2016.03.051
. Epub 2016 Apr 1.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|